相关实验视频

Updated: Jul 5, 2025

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

IL-6和SAA-强度预测者对COVID-19慢性病患者的结果

Rumen Filev^1,2, Mila Lyubomirova^1,2, Boris Bogov^1,2

¹Department of Nephrology, Internal Disease Clinic, University Hospital "Saint Anna", 1750 Sofia, Bulgaria.

International journal of molecular sciences

|January 11, 2024

概括

干白素-6 (IL-6) 和血清粉样蛋白A (SAA) 是关键的炎症生物标志物. 患有慢性病的COVID-19患者的高水平预测死亡率和急性损伤.

科学领域:

生物化学生物化学
免疫学免疫学免疫学
腎臟病學 (nephrology) 是一種醫學專業.

背景情况:

COVID-19对慢性病 (CKD) 患者构成重大风险.
炎症在COVID-19的发病过程中起着至关重要的作用,特别是在诸如CKD患者这样的弱势群体中.

研究的目的:

为了评估炎症生物标志物 - - 介素-6 (IL-6) 和血清粉样蛋白A (SAA) 与COVID-19患者临床结果的相关性.
确定IL-6和SAA对COVID-19患者的死亡率和急性损伤 (AKI) 的预测值,特别是那些患有CKD的人.

主要方法:

120名COVID-19患者 (70名CKD患者) 在急诊室入院时对血清IL-6和SAA水平的前性评估.
生物标志物水平与死亡率,AKI,胸部CT严重性得分和呼吸器需求的相关性分析.
与健康对照组和非COVID-19慢性病患者进行比较.

主要成果:

与对照组相比,COVID-19患者的IL-6和SAA水平显著升高.
两种IL-6和SAA都独立地与死亡率,AKI和肺膜损伤有关.
高基线IL-6和SAA水平与增加的死亡率和通风需求相关,无论住院时间长短.
在胸部CT严重性得分为3-4的患者中观察到较高的死亡率.

结论:

在入院时,IL-6和SAA作为COVID-19患有CKD的患者的宝贵预后生物标志物.
使用这些生物标志物的高风险患者的早期识别可以帮助临床管理和资源分配.

关键词:

艾基 (AKI) 是一个人.在CKD中,它是最好的.在 COVID-19 疫情中,在IL-6的研究中,IL-6被认为是IL-6的基因.这就是SAAA.

更多相关视频

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

Standardized Colon Ascendens Stent Peritonitis in Rats - a Simple, Feasible Animal Model to Induce Septic Acute Kidney Injury

Standardized Colon Ascendens Stent Peritonitis in Rats - a Simple, Feasible Animal Model to Induce Septic Acute Kidney Injury

Published on: February 15, 2022

相关概念视频

The JAK-STAT Signaling Pathway

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...